Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2021-02-09 Director's Dealing
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share transactions (disposals) made by an executive (Park Choon-jae) of Welcron Bio-Tech. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives.
2021-02-09 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the 'Decision to Dispose of Shares and Equity Securities of Another Corporation'. It details a correction (amendment) to a previous filing concerning the disposal of shares in 'Biogenic Korea Co., Ltd.', specifically updating the payment schedule and disposal date. This type of corporate disclosure regarding asset disposal or M&A-related divestment activity falls under the 'M&A Activity' (TAR) category in the provided schema, as it pertains to the sale of a subsidiary or equity interest.
2021-02-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership (specifically convertible bonds) by Baro Saving Bank in Well Biotech Co., Ltd. This type of filing is a mandatory disclosure of significant shareholding changes and falls under the 'Major Shareholding Notification' category.
2021-02-03 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a South Korean company (WellBiotec) regarding the acquisition of shares in another corporation ('타법인 주식 및 출자증권 양수결정'). It includes a 'Correction Report' (정정신고) section detailing changes to the acquisition date and payment schedule, followed by the original 'Major Report' (주요사항보고서) structure required by the Korea Exchange. Since this is a specific corporate action announcement regarding M&A/investment activity that does not fit into the other specialized categories like 10-K or ER, it is classified as a Regulatory Filing.
2021-01-28 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a South Korean company (WellBiotec) regarding a 'Correction Report' (정정신고) for a previous 'Decision to Acquire Shares and Securities of Another Corporation' (타법인 주식 및 출자증권 양수결정). It details changes to the acquisition date and payment schedule. Since this is a specific regulatory disclosure regarding a corporate transaction (M&A/Investment activity) filed with the Korea Exchange/Financial Services Commission, it falls under the category of M&A Activity (TAR) as it pertains to the acquisition of another entity's shares.
2020-12-15 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and a subsequent '정정신고' (Amendment Report). It details the modification of stock option grants, including changes to the number of recipients and the number of shares granted. This type of disclosure regarding stock options and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into the other specialized categories like DIRS (Director's Dealing) or SHA (Share Issue).
2020-12-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.